Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.21.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 3,260,904 $ 3,712,679
General and administrative 1,976,576 1,519,083
Total operating expenses 5,237,480 5,231,762
Loss from operations (5,237,480) (5,231,762)
Other income (expense):    
Interest income 20,033 44,515
Interest expense (2,568) (1,708)
Local business tax (600) (600)
Miscellaneous income 670 1,795
Total other income, net 17,535 44,002
Loss before income taxes (5,219,945) (5,187,760)
Income tax benefit
Net loss $ (5,219,945) $ (5,187,760)
Basic and diluted net loss per share $ (0.05) $ (0.11)
Shares used to compute basic and diluted net loss per share 102,973,369 46,124,803